NCT01808105
Completed
N/A
Growth and Tolerance of Young Infants Fed Infant Formulas
ConditionsGrowth and Tolerance
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Growth and Tolerance
- Sponsor
- Abbott Nutrition
- Enrollment
- 424
- Locations
- 25
- Primary Endpoint
- Weight
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
To evaluate growth and tolerance of healthy term infants fed experimental infant formulas, a commercial infant formula and human breast milk.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Singleton from full term birth with a gestational age 37-42 weeks
- •Birth weight \> 2490 g (\~5 lbs 8 oz)
- •Between 0 and 5 days of age
- •Smoke-free home (no smoking in the house dwelling), and mothers in the breast-fed group are prohibited from smoking during the study period
- •Parent(s) of formula-fed infants have elected not to breastfeed and confirm that their infant has been exclusively formula-fed since birth and confirm their intention is to exclusively feed their infant study infant formula for the duration of the study,
- •Parent(s) of human milk-fed infants have elected to breastfeed and confirm that their infant has been exclusively human milk-fed (not donor milk) since birth and confirm their intention is to continue to exclusively feed human milk with vitamin/mineral supplementation for the duration of the study
- •No administration vitamin or mineral supplements (excluding vitamin or mineral supplements containing vitamin D, if recommended by a healthcare professional), solid foods or juices to infants from enrollment through the duration of the study, unless instructed otherwise by their healthcare professional
Exclusion Criteria
- •Adverse maternal, fetal or infant medical history that has potential effects on tolerance, growth, and/or development
- •Infants using medications, home remedies, herbal preparations, probiotics or rehydration fluids that might affect gastrointestinal (GI) tolerance may not be enrolled
- •Treatment with antibiotics
- •Mother intends to use a combination of breast and formula feeding
Outcomes
Primary Outcomes
Weight
Time Frame: Study Day (SD) 14 - 119
Weight gain per day
Secondary Outcomes
- Length(Study Day (SD) 1, 14, 28, 42, 84 and 119 visits)
- Stool Characteristics(Study Day (SD) 1-28; 3 Day Records prior to SD 42, 84 and 119 visits)
- Feeding Tolerance(Study Day (SD) 1-28; 3 Day Records prior to SD 42, 84 and 119 visits)
- Head Circumference(Study Day (SD) 1, 14, 28, 42, 84 and 119 visits)
Study Sites (25)
Loading locations...
Similar Trials
Terminated
N/A
Growth and Tolerance Trial on Infant Formula With HMOHealthy GrowthNCT04066413FrieslandCampina265
Completed
Phase 3
Evaluation of Safety, Growth, Tolerance and Effects on the Intestinal Fora of a New Milk for Healthy InfantsGrowthNCT00920166Sodilac97
Completed
N/A
Growth of Infants Fed a New Term Infant FormulaHealthyNCT03090360Société des Produits Nestlé (SPN)349
Unknown
N/A
New Infant Formula Supports Adequate Growth in Healthy InfantsInfant DevelopmentNCT03614468Worthy Health80
Terminated
Phase 3
Growth and Tolerance of Healthy Term Infants to a New Infant FormulaHealthy Term InfantsNCT01137877Abbott Nutrition399